166528-78-5

Basic information

• Product Name: Acetic acid (2E,4E,6E)-(R)-1-acetoxymethyl-2,6-dimethyl-8-[2,6,6-trimethyl-cyclohex-2-en-(E)-ylidene]-octa-2,4,6-trienyl ester
• Synonyms: Acetic acid (2E,4E,6E)-(R)-1-acetoxymethyl-2,6-dimethyl-8-[2,6,6-trimethyl-cyclohex-2-en-(E)-ylidene]-octa-2,4,6-trienyl ester
• CAS NO: 166528-78-5
• Molecular Weight: 386.532
• Mol File: 166528-78-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Acetic acid (2E,4E,6E)-(R)-1-acetoxymethyl-2,6-dimethyl-8-[2,6,6-trimethyl-cyclohex-2-en-(E)-ylidene]-octa-2,4,6-trienyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid (2E,4E,6E)-(R)-1-acetoxymethyl-2,6-dimethyl-8-[2,6,6-trimethyl-cyclohex-2-en-(E)-ylidene]-octa-2,4,6-trienyl ester(166528-78-5)
• EPA Substance Registry System: Acetic acid (2E,4E,6E)-(R)-1-acetoxymethyl-2,6-dimethyl-8-[2,6,6-trimethyl-cyclohex-2-en-(E)-ylidene]-octa-2,4,6-trienyl ester(166528-78-5)

Safety Data

• Hazardous Substances Data: 166528-78-5(Hazardous Substances Data)

Upstream product

• 166584-44-7 Acetic acid (3E,5E,7E)-(1S,2S)-1-acetoxymethyl-2-hydroxy-2,6-dimethyl-8-(2,6,6-trimethyl-cyclohex-1-enyl)-octa-3,5,7-trienyl ester 
• 127-47-9 Retinol acetate 
• 166584-42-5 Acetic acid (4E,6E,8E)-(2S,3S)-2,3-dihydroxy-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-4,6,8-trienyl ester 

Downstream Products

• 153219-51-3 (3E,5E,7E)-(R)-3,7-Dimethyl-9-[2,6,6-trimethyl-cyclohex-2-en-(E)-ylidene]-nona-3,5,7-triene-1,2-diol 

Relevant articles and documents

Studies on the apoptotic activity of natural and synthetic retinoids: Discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells

New terphenyl derivatives have been synthesized and tested for their effect on cell survival in serum-free cultures. These compounds protected HL60 cells from death and supported their growth with an activity higher than that of the natural 14-hydroxy-retro-retinol. Terphenyls 26 and 28 also possess antiapoptotic activity on neuronal cells, proving them as possible candidates for the treatment of neurodegenerative and ischemic diseases.